Sanne I - Search Results

1

Cost and cost-effectiveness of switching from stavudine to tenofovir in first-line antiretroviral regimens in South Africa.

Rosen S, Long L, Fox M, Sanne I. Rosen S, et al. Among authors: sanne i. J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):334-44. doi: 10.1097/QAI.0b013e31817ae5ef. J Acquir Immune Defic Syndr. 2008. PMID: 18545151

2

Hard choices: rationing antiretroviral therapy for HIV/AIDS in Africa.

Rosen S, Sanne I, Collier A, Simon JL. Rosen S, et al. Among authors: sanne i. Lancet. 2005 Jan 22-28;365(9456):354-6. doi: 10.1016/S0140-6736(05)17792-7. Lancet. 2005. PMID: 15664233 No abstract available.

3

Rationing antiretroviral therapy for HIV/AIDS in Africa: choices and consequences.

Rosen S, Sanne I, Collier A, Simon JL. Rosen S, et al. Among authors: sanne i. PLoS Med. 2005 Nov;2(11):e303. doi: 10.1371/journal.pmed.0020303. Epub 2005 Sep 20. PLoS Med. 2005. PMID: 16159308 Free PMC article.

4

Cost-effectiveness of alternative strategies for initiating and monitoring highly active antiretroviral therapy in the developing world.

Vijayaraghavan A, Efrusy MB, Mazonson PD, Ebrahim O, Sanne IM, Santas CC. Vijayaraghavan A, et al. J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):91-100. doi: 10.1097/QAI.0b013e3181342564. J Acquir Immune Defic Syndr. 2007. PMID: 17621241

5

Cost to patients of obtaining treatment for HIV/AIDS in South Africa.

Rosen S, Ketlhapile M, Sanne I, DeSilva MB. Rosen S, et al. Among authors: sanne i. S Afr Med J. 2007 Jul;97(7):524-9. S Afr Med J. 2007. PMID: 17805455

6

Characteristics of patients accessing care and treatment for HIV/AIDS at public and nongovernmental sites in South Africa.

Rosen S, Ketlhapile M, Sanne I, DeSilva MB. Rosen S, et al. Among authors: sanne i. J Int Assoc Physicians AIDS Care (Chic). 2008 Jul-Aug;7(4):200-7. doi: 10.1177/1545109708320684. Epub 2008 Jul 14. J Int Assoc Physicians AIDS Care (Chic). 2008. PMID: 18626120

7

The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa.

Rosen S, Long L, Sanne I. Rosen S, et al. Among authors: sanne i. Trop Med Int Health. 2008 Aug;13(8):1005-15. doi: 10.1111/j.1365-3156.2008.02114.x. Epub 2008 Jul 8. Trop Med Int Health. 2008. PMID: 18631314 Free article.

8

Differences in normal activities, job performance and symptom prevalence between patients not yet on antiretroviral therapy and patients initiating therapy in South Africa.

Rosen S, Ketlhapile M, Sanne I, Desilva MB. Rosen S, et al. Among authors: sanne i. AIDS. 2008 Jul;22 Suppl 1:S131-9. doi: 10.1097/01.aids.0000327634.92844.91. AIDS. 2008. PMID: 18664945

9

Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapy.

Westreich DJ, Sanne I, Maskew M, Malope-Kgokong B, Conradie F, Majuba P, Funk MJ, Kaufman JS, Van Rie A, Macphail P. Westreich DJ, et al. Among authors: sanne i. Clin Infect Dis. 2009 Jun 1;48(11):1617-23. doi: 10.1086/598977. Clin Infect Dis. 2009. PMID: 19385733 Free PMC article.

10

Varied patterns of HIV-1 drug resistance on failing first-line antiretroviral therapy in South Africa.

Wallis CL, Mellors JW, Venter WD, Sanne I, Stevens W. Wallis CL, et al. Among authors: sanne i. J Acquir Immune Defic Syndr. 2010 Apr 1;53(4):480-4. doi: 10.1097/QAI.0b013e3181bc478b. J Acquir Immune Defic Syndr. 2010. PMID: 19801944

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters